More Spanish Biotechs To Benefit From Ysios Backing

Latest Fund Closes at €216m

Spain now enjoys a reasonable level of venture capital to help translate its scientific excellence into budding biotechs and the country's major life sciences backer Ysios is looking to unearth more jewels there, as well as in the rest of Europe and North America.

Ysios
Ysios partners (L-R) Raúl Martín-Ruiz, Cristina Garmendia, Julia Salaverria, Karen Wagner, Joël Jean-Mairet, Paula Olazábal

More from Financing

More from Business